{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:19:33Z","timestamp":1782523173564,"version":"3.54.5"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s12035-024-04449-1","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T02:02:07Z","timestamp":1725069727000},"page":"3040-3052","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Apolipoprotein E in Alzheimer\u2019s Disease: Focus on Synaptic Function and Therapeutic Strategy"],"prefix":"10.1007","volume":"62","author":[{"given":"Longjie","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4696-9696","authenticated-orcid":false,"given":"Xiaolei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"key":"4449_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/s0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE et al (2021) Alzheimer\u2019s disease. Lancet (London, England) 397:1577\u20131590. https:\/\/doi.org\/10.1016\/s0140-6736(20)32205-4","journal-title":"Lancet (London, England)"},{"key":"4449_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3233\/jad-161149","volume":"57","author":"M Robinson","year":"2017","unstructured":"Robinson M, Lee BY, Hane FT (2017) Recent Progress in Alzheimer\u2019s Disease Research, Part 2: Genetics and Epidemiology. J Alzheimers Dis 57:317\u2013330. https:\/\/doi.org\/10.3233\/jad-161149","journal-title":"J Alzheimers Dis"},{"key":"4449_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","volume":"19","author":"M Tzioras","year":"2023","unstructured":"Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL (2023) Synaptic degeneration in Alzheimer disease. Nat Rev Neurol 19:19\u201338. https:\/\/doi.org\/10.1038\/s41582-022-00749-z","journal-title":"Nat Rev Neurol"},{"issue":"Pt A","key":"4449_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","volume":"72","author":"Y Huang","year":"2014","unstructured":"Huang Y, Mahley RW (2014) Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases. Neurobiol Dis 72(Pt A):3\u201312. https:\/\/doi.org\/10.1016\/j.nbd.2014.08.025","journal-title":"Neurobiol Dis"},{"key":"4449_CR5","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.tcb.2023.09.004","volume":"34","author":"IA Windham","year":"2024","unstructured":"Windham IA, Cohen S (2024) The cell biology of APOE in the brain. Trends Cell Biol 34:338\u2013348. https:\/\/doi.org\/10.1016\/j.tcb.2023.09.004","journal-title":"Trends Cell Biol"},{"key":"4449_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.apsb.2021.10.002","volume":"12","author":"BR Troutwine","year":"2022","unstructured":"Troutwine BR, Hamid L, Lysaker CR, Strope TA, Wilkins HM (2022) Apolipoprotein E and Alzheimer\u2019s disease. Acta pharmaceutica Sinica B 12:496\u2013510. https:\/\/doi.org\/10.1016\/j.apsb.2021.10.002","journal-title":"Acta pharmaceutica Sinica B"},{"key":"4449_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. The Lancet Neurology 20:68\u201380. https:\/\/doi.org\/10.1016\/S1474-4422(20)30412-9","journal-title":"The Lancet Neurology"},{"key":"4449_CR8","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens YA, Zhao N, Liu CC, Kanekiyo T, Yang AJ, Goate AM et al (2022) ApoE Cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron 110:1304\u20131317. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.004","journal-title":"Neuron"},{"key":"4449_CR9","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1172\/jci112130","volume":"76","author":"JK Boyles","year":"1985","unstructured":"Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Investig 76:1501\u20131513. https:\/\/doi.org\/10.1172\/jci112130","journal-title":"J Clin Investig"},{"key":"4449_CR10","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1161\/01.STR.0000064320.73388.C6","volume":"34","author":"K Aoki","year":"2003","unstructured":"Aoki K, Uchihara T, Sanjo N, Nakamura A, Ikeda K, Tsuchiya K et al (2003) Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. Stroke 34:875\u2013880. https:\/\/doi.org\/10.1161\/01.STR.0000064320.73388.C6","journal-title":"Stroke"},{"key":"4449_CR11","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41593-019-0539-4","volume":"22","author":"A Grubman","year":"2019","unstructured":"Grubman A, Chew G, Ouyang JF, Sun G, Choo XY, McLean C et al (2019) A single-cell atlas of entorhinal cortex from individuals with Alzheimer\u2019s disease reveals cell-type-specific gene expression regulation. Nat Neurosci 22:2087\u20132097. https:\/\/doi.org\/10.1038\/s41593-019-0539-4","journal-title":"Nat Neurosci"},{"key":"4449_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/iub.1314","volume":"66","author":"MC Phillips","year":"2014","unstructured":"Phillips MC (2014) Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life 66:616\u2013623. https:\/\/doi.org\/10.1002\/iub.1314","journal-title":"IUBMB Life"},{"key":"4449_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/01.atv.8.1.1","volume":"8","author":"J Davignon","year":"1988","unstructured":"Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis (Dallas, Tex.) 8:1\u201321. https:\/\/doi.org\/10.1161\/01.atv.8.1.1","journal-title":"Arteriosclerosis (Dallas, Tex.)"},{"key":"4449_CR14","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s11064-018-2629-1","volume":"44","author":"SS Mu\u00f1oz","year":"2019","unstructured":"Mu\u00f1oz SS, Garner B, Ooi L (2019) Understanding the Role of ApoE Fragments in Alzheimer\u2019s Disease. Neurochem Res 44:1297\u20131305. https:\/\/doi.org\/10.1007\/s11064-018-2629-1","journal-title":"Neurochem Res"},{"key":"4449_CR15","doi-asserted-by":"publisher","first-page":"27273","DOI":"10.1074\/jbc.M109.014464","volume":"284","author":"N Zhong","year":"2009","unstructured":"Zhong N, Ramaswamy G, Weisgraber KH (2009) Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function. J Biol Chem 284:27273\u201327280. https:\/\/doi.org\/10.1074\/jbc.M109.014464","journal-title":"J Biol Chem"},{"key":"4449_CR16","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1073\/pnas.151254698","volume":"98","author":"Y Huang","year":"2001","unstructured":"Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW (2001) Apolipoprotein E fragments present in Alzheimer\u2019s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA 98:8838\u20138843. https:\/\/doi.org\/10.1073\/pnas.151254698","journal-title":"Proc Natl Acad Sci USA"},{"key":"4449_CR17","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/atvbaha.116.307023","volume":"36","author":"RW Mahley","year":"2016","unstructured":"Mahley RW (2016) Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. Arterioscler Thromb Vasc Biol 36:1305\u20131315. https:\/\/doi.org\/10.1161\/atvbaha.116.307023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4449_CR18","doi-asserted-by":"publisher","first-page":"19053","DOI":"10.1074\/jbc.271.32.19053","volume":"271","author":"LM Dong","year":"1996","unstructured":"Dong LM, Weisgraber KH (1996) Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 271:19053\u201319057. https:\/\/doi.org\/10.1074\/jbc.271.32.19053","journal-title":"J Biol Chem"},{"key":"4449_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jalz.2008.01.006","volume":"4","author":"N Zhong","year":"2008","unstructured":"Zhong N, Scearce-Levie K, Ramaswamy G, Weisgraber KH (2008) Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in mice. Alzheimer\u2019s Dementia 4:179\u2013192. https:\/\/doi.org\/10.1016\/j.jalz.2008.01.006","journal-title":"Alzheimer's Dementia"},{"key":"4449_CR20","doi-asserted-by":"publisher","first-page":"11587","DOI":"10.1073\/pnas.201279298","volume":"98","author":"RL Raffai","year":"2001","unstructured":"Raffai RL, Dong LM, Farese RV Jr, Weisgraber KH (2001) Introduction of human apolipoprotein E4 \u201cdomain interaction\u201d into mouse apolipoprotein E. Proc Natl Acad Sci USA 98:11587\u201311591. https:\/\/doi.org\/10.1073\/pnas.201279298","journal-title":"Proc Natl Acad Sci USA"},{"key":"4449_CR21","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","volume":"286","author":"HK Chen","year":"2011","unstructured":"Chen HK, Ji ZS, Dodson SE, Miranda RD, Rosenblum CI, Reynolds IJ et al (2011) Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease. J Biol Chem 286:5215\u20135221. https:\/\/doi.org\/10.1074\/jbc.M110.151084","journal-title":"J Biol Chem"},{"key":"4449_CR22","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1074\/jbc.M113.497909","volume":"289","author":"SO Adeosun","year":"2014","unstructured":"Adeosun SO, Hou X, Zheng B, Stockmeier C, Ou X, Paul I et al (2014) Cognitive deficits and disruption of neurogenesis in a mouse model of apolipoprotein E4 domain interaction. J Biol Chem 289:2946\u20132959. https:\/\/doi.org\/10.1074\/jbc.M113.497909","journal-title":"J Biol Chem"},{"key":"4449_CR23","doi-asserted-by":"publisher","first-page":"112196","DOI":"10.1016\/j.celrep.2023.112196","volume":"42","author":"S Lee","year":"2023","unstructured":"Lee S, Devanney NA, Golden LR, Smith CT, Schwartz JL, Walsh AE et al (2023) APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell Rep 42:112196. https:\/\/doi.org\/10.1016\/j.celrep.2023.112196","journal-title":"Cell Rep"},{"key":"4449_CR24","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s41593-021-00851-3","volume":"24","author":"KA Zalocusky","year":"2021","unstructured":"Zalocusky KA, Najm R, Taubes AL, Hao Y, Yoon SY, Koutsodendris N et al (2021) Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer\u2019s disease. Nat Neurosci 24:786\u2013798. https:\/\/doi.org\/10.1038\/s41593-021-00851-3","journal-title":"Nat Neurosci"},{"key":"4449_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","volume":"44","author":"RC Malenka","year":"2004","unstructured":"Malenka RC, Bear MF (2004) LTP and LTD: an embarrassment of riches. Neuron 44:5\u201321. https:\/\/doi.org\/10.1016\/j.neuron.2004.09.012","journal-title":"Neuron"},{"key":"4449_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/361031a0","volume":"361","author":"TV Bliss","year":"1993","unstructured":"Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31\u201339. https:\/\/doi.org\/10.1038\/361031a0","journal-title":"Nature"},{"key":"4449_CR27","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1097\/00001756-200412030-00020","volume":"15","author":"BL Trommer","year":"2004","unstructured":"Trommer BL, Shah C, Yun SH, Gamkrelidze G, Pasternak ES, Ye GL et al (2004) ApoE isoform affects LTP in human targeted replacement mice. NeuroReport 15:2655\u20132658. https:\/\/doi.org\/10.1097\/00001756-200412030-00020","journal-title":"NeuroReport"},{"key":"4449_CR28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/cns.12720","volume":"23","author":"GZ Sun","year":"2017","unstructured":"Sun GZ, He YC, Ma XK, Li ST, Chen DJ, Gao M et al (2017) Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene. CNS Neurosci Ther 23:748\u2013758. https:\/\/doi.org\/10.1111\/cns.12720","journal-title":"CNS Neurosci Ther"},{"key":"4449_CR29","doi-asserted-by":"publisher","first-page":"39944","DOI":"10.1074\/jbc.M205147200","volume":"277","author":"EJ Weeber","year":"2002","unstructured":"Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD et al (2002) Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277:39944\u201339952. https:\/\/doi.org\/10.1074\/jbc.M205147200","journal-title":"J Biol Chem"},{"key":"4449_CR30","doi-asserted-by":"publisher","first-page":"10771","DOI":"10.1016\/S0021-9258(18)87014-4","volume":"265","author":"RC Kowal","year":"1990","unstructured":"Kowal RC, Herz J, Weisgraber KH, Mahley RW, Brown MS, Goldstein JL (1990) Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem 265:10771\u201310779","journal-title":"J Biol Chem"},{"key":"4449_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.nbd.2004.08.011","volume":"18","author":"BL Trommer","year":"2005","unstructured":"Trommer BL, Shah C, Yun SH, Gamkrelidze G, Pasternak ES, Stine WB et al (2005) ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-beta1-42. Neurobiol Dis 18:75\u201382. https:\/\/doi.org\/10.1016\/j.nbd.2004.08.011","journal-title":"Neurobiol Dis"},{"key":"4449_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1750-1326-9-48","volume":"9","author":"S Tu","year":"2014","unstructured":"Tu S, Okamoto S, Lipton SA, Xu H (2014) Oligomeric A\u03b2-induced synaptic dysfunction in Alzheimer\u2019s disease. Mol Neurodegener 9:48. https:\/\/doi.org\/10.1186\/1750-1326-9-48","journal-title":"Mol Neurodegener"},{"key":"4449_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.nbd.2015.10.019","volume":"85","author":"M Lei","year":"2016","unstructured":"Lei M, Xu H, Li Z, Wang Z, O\u2019Malley TT, Zhang D et al (2016) Soluble A\u03b2 oligomers impair hippocampal LTP by disrupting glutamatergic\/GABAergic balance. Neurobiol Dis 85:111\u2013121. https:\/\/doi.org\/10.1016\/j.nbd.2015.10.019","journal-title":"Neurobiol Dis"},{"key":"4449_CR34","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS et al (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535\u2013539. https:\/\/doi.org\/10.1038\/416535a","journal-title":"Nature"},{"key":"4449_CR35","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I et al (2008) Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat Med 14:837\u2013842. https:\/\/doi.org\/10.1038\/nm1782","journal-title":"Nat Med"},{"key":"4449_CR36","doi-asserted-by":"publisher","unstructured":"Agnello L, Lo Sasso B, Vidali M, Scazzone C, Piccoli T, Gambino CM et al (2021) Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer's Disease. Diagnostics (Basel), 11. https:\/\/doi.org\/10.3390\/diagnostics11122339","DOI":"10.3390\/diagnostics11122339"},{"key":"4449_CR37","doi-asserted-by":"publisher","first-page":"11232","DOI":"10.1073\/pnas.210184697","volume":"97","author":"JH Pak","year":"2000","unstructured":"Pak JH, Huang FL, Li J, Balschun D, Reymann KG, Chiang C et al (2000) Involvement of neurogranin in the modulation of calcium\/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice. Proc Natl Acad Sci USA 97:11232\u201311237. https:\/\/doi.org\/10.1073\/pnas.210184697","journal-title":"Proc Natl Acad Sci USA"},{"key":"4449_CR38","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jalz.2016.05.003","volume":"12","author":"X Sun","year":"2016","unstructured":"Sun X, Dong C, Levin B, Crocco E, Loewenstein D, Zetterberg H et al (2016) APOE epsilon4 carriers may undergo synaptic damage conferring risk of Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 12:1159\u20131166. https:\/\/doi.org\/10.1016\/j.jalz.2016.05.003","journal-title":"Alzheimer's Dementia"},{"key":"4449_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1750-3639.1993.tb00729.x","volume":"3","author":"G Thiel","year":"1993","unstructured":"Thiel G (1993) Synapsin I, synapsin II, and synaptophysin: marker proteins of synaptic vesicles. Brain Pathology (Zurich, Switzerland) 3:87\u201395. https:\/\/doi.org\/10.1111\/j.1750-3639.1993.tb00729.x","journal-title":"Brain Pathology (Zurich, Switzerland)"},{"key":"4449_CR40","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/s0092-8674(85)80082-9","volume":"41","author":"B Wiedenmann","year":"1985","unstructured":"Wiedenmann B, Franke WW (1985) Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41:1017\u20131028. https:\/\/doi.org\/10.1016\/s0092-8674(85)80082-9","journal-title":"Cell"},{"key":"4449_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","volume":"60","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Nwabuisi-Heath E, Dumanis SB, Tai LM, Yu C, Rebeck GW et al (2012) APOE genotype alters glial activation and loss of synaptic markers in mice. Glia 60:559\u2013569. https:\/\/doi.org\/10.1002\/glia.22289","journal-title":"Glia"},{"key":"4449_CR42","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.neurobiolaging.2005.04.008","volume":"27","author":"S Love","year":"2006","unstructured":"Love S, Siew LK, Dawbarn D, Wilcock GK, Ben-Shlomo Y, Allen SJ (2006) Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiol Aging 27:797\u2013803. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.04.008","journal-title":"Neurobiol Aging"},{"key":"4449_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fncel.2015.00103","volume":"9","author":"O Aboud","year":"2015","unstructured":"Aboud O, Parcon PA, DeWall KM, Liu L, Mrak RE, Griffin WS (2015) Aging, Alzheimer\u2019s, and APOE genotype influence the expression and neuronal distribution patterns of microtubule motor protein dynactin-P50. Front Cell Neurosci 9:103. https:\/\/doi.org\/10.3389\/fncel.2015.00103","journal-title":"Front Cell Neurosci"},{"key":"4449_CR44","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuint.2006.05.004","volume":"49","author":"RK Tannenberg","year":"2006","unstructured":"Tannenberg RK, Scott HL, Tannenberg AE, Dodd PR (2006) Selective loss of synaptic proteins in Alzheimer\u2019s disease: evidence for an increased severity with APOE varepsilon4. Neurochem Int 49:631\u2013639. https:\/\/doi.org\/10.1016\/j.neuint.2006.05.004","journal-title":"Neurochem Int"},{"key":"4449_CR45","doi-asserted-by":"publisher","first-page":"11035","DOI":"10.1523\/jneurosci.3722-04.2004","volume":"24","author":"YN Dong","year":"2004","unstructured":"Dong YN, Waxman EA, Lynch DR (2004) Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor. J Neurosci 24:11035\u201311045. https:\/\/doi.org\/10.1523\/jneurosci.3722-04.2004","journal-title":"J Neurosci"},{"key":"4449_CR46","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1126\/science.284.5421.1845","volume":"284","author":"R Sattler","year":"1999","unstructured":"Sattler R, Xiong Z, Lu WY, Hafner M, MacDonald JF, Tymianski M (1999) Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science (New York, N.Y.) 284:1845\u20131848. https:\/\/doi.org\/10.1126\/science.284.5421.1845","journal-title":"Science (New York, N.Y.)"},{"key":"4449_CR47","doi-asserted-by":"publisher","first-page":"8836","DOI":"10.1038\/ncomms9836","volume":"6","author":"I Leshchyns'ka","year":"2015","unstructured":"Leshchyns\u2019ka I, Liew HT, Shepherd C, Halliday GM, Stevens CH, Ke YD et al (2015) A\u03b2-dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss in Alzheimer\u2019s disease. Nat Commun 6:8836. https:\/\/doi.org\/10.1038\/ncomms9836","journal-title":"Nat Commun"},{"key":"4449_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuron.2015.05.043","volume":"87","author":"J Nishiyama","year":"2015","unstructured":"Nishiyama J, Yasuda R (2015) Biochemical Computation for Spine Structural Plasticity. Neuron 87:63\u201375. https:\/\/doi.org\/10.1016\/j.neuron.2015.05.043","journal-title":"Neuron"},{"key":"4449_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neuroscience.2003.08.007","volume":"122","author":"Y Ji","year":"2003","unstructured":"Ji Y, Gong Y, Gan W, Beach T, Holtzman DM, Wisniewski T (2003) Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer\u2019s disease patients. Neuroscience 122:305\u2013315. https:\/\/doi.org\/10.1016\/j.neuroscience.2003.08.007","journal-title":"Neuroscience"},{"key":"4449_CR50","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/s0306-4522(00)00065-8","volume":"97","author":"K Cambon","year":"2000","unstructured":"Cambon K, Davies HA, Stewart MG (2000) Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice. Neuroscience 97:685\u2013692. https:\/\/doi.org\/10.1016\/s0306-4522(00)00065-8","journal-title":"Neuroscience"},{"key":"4449_CR51","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","volume":"68","author":"SW Scheff","year":"2007","unstructured":"Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ (2007) Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68:1501\u20131508. https:\/\/doi.org\/10.1212\/01.wnl.0000260698.46517.8f","journal-title":"Neurology"},{"key":"4449_CR52","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging 27:1372\u20131384. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.09.012","journal-title":"Neurobiol Aging"},{"key":"4449_CR53","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.nbd.2004.10.013","volume":"18","author":"C Wang","year":"2005","unstructured":"Wang C, Wilson WA, Moore SD, Mace BE, Maeda N, Schmechel DE et al (2005) Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology. Neurobiol Dis 18:390\u2013398. https:\/\/doi.org\/10.1016\/j.nbd.2004.10.013","journal-title":"Neurobiol Dis"},{"key":"4449_CR54","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.neuroscience.2010.10.027","volume":"171","author":"RC Klein","year":"2010","unstructured":"Klein RC, Mace BE, Moore SD, Sullivan PM (2010) Progressive loss of synaptic integrity in human apolipoprotein E4 targeted replacement mice and attenuation by apolipoprotein E2. Neuroscience 171:1265\u20131272. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.10.027","journal-title":"Neuroscience"},{"key":"4449_CR55","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.neurobiolaging.2014.02.019","volume":"35","author":"RC Klein","year":"2014","unstructured":"Klein RC, Acheson SK, Mace BE, Sullivan PM, Moore SD (2014) Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice. Neurobiol Aging 35:2046\u20132052. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.02.019","journal-title":"Neurobiol Aging"},{"key":"4449_CR56","doi-asserted-by":"publisher","unstructured":"Hudry E, Klickstein J, Cannavo C, Jackson R, Muzikansky A, Gandhi S et al (2019) Opposing Roles of apolipoprotein E in aging and neurodegeneration. Life Sci Alliance 2. https:\/\/doi.org\/10.26508\/lsa.201900325","DOI":"10.26508\/lsa.201900325"},{"key":"4449_CR57","doi-asserted-by":"publisher","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","volume":"29","author":"SB Dumanis","year":"2009","unstructured":"Dumanis SB, Tesoriero JA, Babus LW, Nguyen MT, Trotter JH, Ladu MJ et al (2009) ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci 29:15317\u201315322. https:\/\/doi.org\/10.1523\/JNEUROSCI.4026-09.2009","journal-title":"J Neurosci"},{"key":"4449_CR58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0969-9961(03)00045-7","volume":"13","author":"O Levi","year":"2003","unstructured":"Levi O, Jongen-Relo AL, Feldon J, Roses AD, Michaelson DM (2003) ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol Dis 13:273\u2013282. https:\/\/doi.org\/10.1016\/s0969-9961(03)00045-7","journal-title":"Neurobiol Dis"},{"key":"4449_CR59","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jns.2004.11.035","volume":"229\u2013230","author":"O Levi","year":"2005","unstructured":"Levi O, Jongen-Relo AL, Feldon J, Michaelson DM (2005) Brain area- and isoform-specific inhibition of synaptic plasticity by apoE4. J Neurol Sci 229\u2013230:241\u2013248. https:\/\/doi.org\/10.1016\/j.jns.2004.11.035","journal-title":"J Neurol Sci"},{"key":"4449_CR60","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/JAD-190564","volume":"72","author":"I Har-Paz","year":"2019","unstructured":"Har-Paz I, Roisman N, Michaelson DM, Moran A (2019) Extra-Hippocampal Learning Deficits in Young Apolipoprotein E4 Mice and Their Synaptic Underpinning. J Alzheimers Dis 72:71\u201382. https:\/\/doi.org\/10.3233\/JAD-190564","journal-title":"J Alzheimers Dis"},{"key":"4449_CR61","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1212\/wnl.56.12.1696","volume":"56","author":"E Ghebremedhin","year":"2001","unstructured":"Ghebremedhin E, Schultz C, Thal DR, R\u00fcb U, Ohm TG, Braak E et al (2001) Gender and age modify the association between APOE and AD-related neuropathology. Neurology 56:1696\u20131701. https:\/\/doi.org\/10.1212\/wnl.56.12.1696","journal-title":"Neurology"},{"key":"4449_CR62","doi-asserted-by":"publisher","first-page":"8254","DOI":"10.1523\/jneurosci.0305-12.2012","volume":"32","author":"JS Damoiseaux","year":"2012","unstructured":"Damoiseaux JS, Seeley WW, Zhou J, Shirer WR, Coppola G, Karydas A et al (2012) Gender modulates the APOE \u03b54 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. J Neurosci 32:8254\u20138262. https:\/\/doi.org\/10.1523\/jneurosci.0305-12.2012","journal-title":"J Neurosci"},{"key":"4449_CR63","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1523\/jneurosci.18-09-03180.1998","volume":"18","author":"DJ Stone","year":"1998","unstructured":"Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Finch CE (1998) Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer\u2019s disease. J Neurosci 18:3180\u20133185. https:\/\/doi.org\/10.1523\/jneurosci.18-09-03180.1998","journal-title":"J Neurosci"},{"key":"4449_CR64","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1017\/S1461145714000601","volume":"17","author":"L Shi","year":"2014","unstructured":"Shi L, Du X, Zhou H, Tao C, Liu Y, Meng F et al (2014) Cumulative effects of the ApoE genotype and gender on the synaptic proteome and oxidative stress in the mouse brain. Int J Neuropsychopharmacol 17:1863\u20131879. https:\/\/doi.org\/10.1017\/S1461145714000601","journal-title":"Int J Neuropsychopharmacol"},{"key":"4449_CR65","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature12776","volume":"504","author":"WS Chung","year":"2013","unstructured":"Chung WS, Clarke LE, Wang GX, Stafford BK, Sher A, Chakraborty C et al (2013) Astrocytes mediate synapse elimination through MEGF10 and MERTK pathways. Nature 504:394\u2013400. https:\/\/doi.org\/10.1038\/nature12776","journal-title":"Nature"},{"key":"4449_CR66","doi-asserted-by":"publisher","first-page":"10186","DOI":"10.1073\/pnas.1609896113","volume":"113","author":"WS Chung","year":"2016","unstructured":"Chung WS, Verghese PB, Chakraborty C, Joung J, Hyman BT, Ulrich JD et al (2016) Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes. Proc Natl Acad Sci USA 113:10186\u201310191. https:\/\/doi.org\/10.1073\/pnas.1609896113","journal-title":"Proc Natl Acad Sci USA"},{"key":"4449_CR67","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1073\/pnas.0914984107","volume":"107","author":"Y Chen","year":"2010","unstructured":"Chen Y, Durakoglugil MS, Xian X, Herz J (2010) ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc Natl Acad Sci USA 107:12011\u201312016. https:\/\/doi.org\/10.1073\/pnas.0914984107","journal-title":"Proc Natl Acad Sci USA"},{"key":"4449_CR68","doi-asserted-by":"publisher","first-page":"8997","DOI":"10.1021\/jm3008618","volume":"55","author":"RW Mahley","year":"2012","unstructured":"Mahley RW, Huang Y (2012) Small-Molecule Structure Correctors Target Abnormal Protein Structure and Function: Structure Corrector Rescue of Apolipoprotein E4\u2013Associated Neuropathology. J Med Chem 55:8997\u20139008. https:\/\/doi.org\/10.1021\/jm3008618","journal-title":"J Med Chem"},{"key":"4449_CR69","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/glia.22389","volume":"61","author":"DP Schafer","year":"2013","unstructured":"Schafer DP, Lehrman EK, Stevens B (2013) The \u201cquad-partite\u201d synapse: microglia-synapse interactions in the developing and mature CNS. Glia 61:24\u201336. https:\/\/doi.org\/10.1002\/glia.22389","journal-title":"Glia"},{"key":"4449_CR70","doi-asserted-by":"publisher","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S et al (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science (New York, N.Y.), 352:712\u2013716. https:\/\/doi.org\/10.1126\/science.aad8373","DOI":"10.1126\/science.aad8373"},{"key":"4449_CR71","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/s41590-023-01640-9","volume":"24","author":"CC Liu","year":"2023","unstructured":"Liu CC, Wang N, Chen Y, Inoue Y, Shue F, Ren Y et al (2023) Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer\u2019s disease. Nat Immunol 24:1854\u20131866. https:\/\/doi.org\/10.1038\/s41590-023-01640-9","journal-title":"Nat Immunol"},{"key":"4449_CR72","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang J, Liu Q (2015) Cholesterol metabolism and homeostasis in the brain. Protein Cell 6:254\u2013264. https:\/\/doi.org\/10.1007\/s13238-014-0131-3","journal-title":"Protein Cell"},{"key":"4449_CR73","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1523\/jneurosci.2994-18.2019","volume":"39","author":"YA Huang","year":"2019","unstructured":"Huang YA, Zhou B, Nabet AM, Wernig M, S\u00fcdhof TC (2019) Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer\u2019s Disease Risk. J Neurosci 39:7408\u20137427. https:\/\/doi.org\/10.1523\/jneurosci.2994-18.2019","journal-title":"J Neurosci"},{"key":"4449_CR74","doi-asserted-by":"publisher","first-page":"18937","DOI":"10.1073\/pnas.1911452116","volume":"116","author":"Q Wang","year":"2019","unstructured":"Wang Q, Chen M, Schafer NP, Bueno C, Song SS, Hudmon A et al (2019) Assemblies of calcium\/calmodulin-dependent kinase II with actin and their dynamic regulation by calmodulin in dendritic spines. Proc Natl Acad Sci USA 116:18937\u201318942. https:\/\/doi.org\/10.1073\/pnas.1911452116","journal-title":"Proc Natl Acad Sci USA"},{"key":"4449_CR75","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/WNR.0000000000000811","volume":"28","author":"AL Neustadtl","year":"2017","unstructured":"Neustadtl AL, Winston CN, Parsadanian M, Main BS, Villapol S, Burns MP (2017) Reduced cortical excitatory synapse number in APOE4 mice is associated with increased calcineurin activity. NeuroReport 28:618\u2013624. https:\/\/doi.org\/10.1097\/WNR.0000000000000811","journal-title":"NeuroReport"},{"key":"4449_CR76","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1002\/alz.13775","volume":"20","author":"K He","year":"2024","unstructured":"He K, Li B, Wang J, Wang Y, You Z, Chen X et al (2024) APOE \u03b54 is associated with decreased synaptic density in cognitively impaired participants. Alzheimer\u2019s Dementia 20:3157\u20133166. https:\/\/doi.org\/10.1002\/alz.13775","journal-title":"Alzheimer's Dementia"},{"key":"4449_CR77","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10571-011-9691-4","volume":"31","author":"KC Wilcox","year":"2011","unstructured":"Wilcox KC, Lacor PN, Pitt J, Klein WL (2011) A\u03b2 oligomer-induced synapse degeneration in Alzheimer\u2019s disease. Cell Mol Neurobiol 31:939\u2013948. https:\/\/doi.org\/10.1007\/s10571-011-9691-4","journal-title":"Cell Mol Neurobiol"},{"key":"4449_CR78","doi-asserted-by":"publisher","unstructured":"Puzzo D (2019) A\u03b2 oligomers: role at the synapse. Aging, 11:1077\u20131078. https:\/\/doi.org\/10.18632\/aging.101818","DOI":"10.18632\/aging.101818"},{"key":"4449_CR79","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/jneurosci.1542-12.2012","volume":"32","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Serrano-Pozo A, Hori Y, Adams KW, Takeda S, Banerji AO et al (2012) Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide. J Neurosci 32:15181\u201315192. https:\/\/doi.org\/10.1523\/jneurosci.1542-12.2012","journal-title":"J Neurosci"},{"key":"4449_CR80","doi-asserted-by":"publisher","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW et al (2011) Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Science translational medicine, 3:89ra57. https:\/\/doi.org\/10.1126\/scitranslmed.3002156","DOI":"10.1126\/scitranslmed.3002156"},{"key":"4449_CR81","doi-asserted-by":"publisher","unstructured":"Hudry E, Dashkoff J, Roe AD, Takeda S, Koffie RM, Hashimoto T et al (2013) Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain. Science translational medicine, 5:212ra161. https:\/\/doi.org\/10.1126\/scitranslmed.3007000","DOI":"10.1126\/scitranslmed.3007000"},{"key":"4449_CR82","doi-asserted-by":"publisher","first-page":"18787","DOI":"10.1073\/pnas.0604011103","volume":"103","author":"MJ Sadowski","year":"2006","unstructured":"Sadowski MJ, Pankiewicz J, Scholtzova H, Mehta PD, Prelli F, Quartermain D et al (2006) Blocking the apolipoprotein E\/amyloid-beta interaction as a potential therapeutic approach for Alzheimer\u2019s disease. Proc Natl Acad Sci USA 103:18787\u201318792. https:\/\/doi.org\/10.1073\/pnas.0604011103","journal-title":"Proc Natl Acad Sci USA"},{"key":"4449_CR83","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/s41380-022-01565-z","volume":"27","author":"L Peng","year":"2022","unstructured":"Peng L, Bestard-Lorigados I, Song W (2022) The synapse as a treatment avenue for Alzheimer\u2019s Disease. Mol Psychiatry 27:2940\u20132949. https:\/\/doi.org\/10.1038\/s41380-022-01565-z","journal-title":"Mol Psychiatry"},{"key":"4449_CR84","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","volume":"100","author":"B Dejanovic","year":"2018","unstructured":"Dejanovic B, Huntley MA, De Mazi\u00e8re A, Meilandt WJ, Wu T, Srinivasan K et al (2018) Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies. Neuron 100:1322-1336.e1327. https:\/\/doi.org\/10.1016\/j.neuron.2018.10.014","journal-title":"Neuron"},{"key":"4449_CR85","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi Y, Manis M, Long J, Wang K, Sullivan PM, Remolina Serrano J et al (2019) Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med 216:2546\u20132561. https:\/\/doi.org\/10.1084\/jem.20190980","journal-title":"J Exp Med"},{"key":"4449_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40478-024-01731-0","volume":"12","author":"AC Raulin","year":"2024","unstructured":"Raulin AC, Doss SV, Heckman MG, Craver EC, Li Z, Ikezu TC et al (2024) Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer\u2019s disease. Acta Neuropathol Commun 12:25. https:\/\/doi.org\/10.1186\/s40478-024-01731-0","journal-title":"Acta Neuropathol Commun"},{"key":"4449_CR87","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/jneurosci.4315-03.2004","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht WJ, Harris FM, Chang S, Tesseur I, Yu GQ, Xu Q et al (2004) Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci 24:2527\u20132534. https:\/\/doi.org\/10.1523\/jneurosci.4315-03.2004","journal-title":"J Neurosci"},{"key":"4449_CR88","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2108870119","volume":"119","author":"SR Saroja","year":"2022","unstructured":"Saroja SR, Gorbachev K, Julia T, Goate AM, Pereira AC (2022) Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation. Proc Natl Acad Sci USA 119:e2108870119. https:\/\/doi.org\/10.1073\/pnas.2108870119","journal-title":"Proc Natl Acad Sci USA"},{"key":"4449_CR89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2015.09.011","volume":"37","author":"JM Farfel","year":"2016","unstructured":"Farfel JM, Yu L, De Jager PL, Schneider JA, Bennett DA (2016) Association of APOE with tau-tangle pathology with and without \u03b2-amyloid. Neurobiol Aging 37:19\u201325. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.09.011","journal-title":"Neurobiol Aging"},{"key":"4449_CR90","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00401-024-02744-8","volume":"147","author":"M Thierry","year":"2024","unstructured":"Thierry M, Ponce J, Mart\u00e0-Ariza M, Askenazi M, Faustin A, Leitner D et al (2024) The influence of APOE(\u03b54) on the pTau interactome in sporadic Alzheimer\u2019s disease. Acta Neuropathol 147:91. https:\/\/doi.org\/10.1007\/s00401-024-02744-8","journal-title":"Acta Neuropathol"},{"key":"4449_CR91","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3233\/jad-160702","volume":"57","author":"L Guo","year":"2017","unstructured":"Guo L, Tian J, Du H (2017) Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer\u2019s Disease. J Alzheimers Dis 57:1071\u20131086. https:\/\/doi.org\/10.3233\/jad-160702","journal-title":"J Alzheimers Dis"},{"key":"4449_CR92","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2174\/1570159x14666160414111821","volume":"15","author":"V Todorova","year":"2017","unstructured":"Todorova V, Blokland A (2017) Mitochondria and Synaptic Plasticity in the Mature and Aging Nervous System. Curr Neuropharmacol 15:166\u2013173. https:\/\/doi.org\/10.2174\/1570159x14666160414111821","journal-title":"Curr Neuropharmacol"},{"key":"4449_CR93","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1093\/hmg\/ddw312","volume":"25","author":"R Kandimalla","year":"2016","unstructured":"Kandimalla R, Manczak M, Fry D, Suneetha Y, Sesaki H, Reddy PH (2016) Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer\u2019s disease. Hum Mol Genet 25:4881\u20134897. https:\/\/doi.org\/10.1093\/hmg\/ddw312","journal-title":"Hum Mol Genet"},{"key":"4449_CR94","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1111\/jcmm.15194","volume":"24","author":"LD Popov","year":"2020","unstructured":"Popov LD (2020) Mitochondrial biogenesis: An update. J Cell Mol Med 24:4892\u20134899. https:\/\/doi.org\/10.1111\/jcmm.15194","journal-title":"J Cell Mol Med"},{"key":"4449_CR95","doi-asserted-by":"publisher","first-page":"e2404","DOI":"10.1212\/WNL.0000000000009582","volume":"94","author":"J Yin","year":"2020","unstructured":"Yin J, Reiman EM, Beach TG, Serrano GE, Sabbagh MN, Nielsen M et al (2020) Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology 94:e2404\u2013e2411. https:\/\/doi.org\/10.1212\/WNL.0000000000009582","journal-title":"Neurology"},{"key":"4449_CR96","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/1531-8249(200009)48:3","volume":"48","author":"GE Gibson","year":"2000","unstructured":"Gibson GE, Haroutunian V, Zhang H, Park LCH, Shi Q, Lesser M et al (2000) Mitochondrial damage in Alzheimer\u2019s disease varies with apolipoprotein E genotype. Ann Neurol 48:297\u2013303. https:\/\/doi.org\/10.1002\/1531-8249(200009)48:3","journal-title":"Ann Neurol"},{"key":"4449_CR97","doi-asserted-by":"publisher","unstructured":"Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A et al (2022) Alzheimer's Disease: Treatment Strategies and Their Limitations. International journal of molecular sciences, 23. https:\/\/doi.org\/10.3390\/ijms232213954","DOI":"10.3390\/ijms232213954"},{"key":"4449_CR98","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M et al (2023) Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med 388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"key":"4449_CR99","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1682","volume":"374","author":"S Walsh","year":"2021","unstructured":"Walsh S, Merrick R, Milne R, Brayne C (2021) Aducanumab for Alzheimer\u2019s disease? BMJ (Clinical research ed) 374:n1682. https:\/\/doi.org\/10.1136\/bmj.n1682","journal-title":"BMJ (Clinical research ed)"},{"key":"4449_CR100","doi-asserted-by":"publisher","first-page":"12260","DOI":"10.1073\/pnas.92.26.12260","volume":"92","author":"J Poirier","year":"1995","unstructured":"Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D et al (1995) Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 92:12260\u201312264. https:\/\/doi.org\/10.1073\/pnas.92.26.12260","journal-title":"Proc Natl Acad Sci USA"},{"key":"4449_CR101","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1212\/WNL.0b013e3181c67808","volume":"73","author":"S Salloway","year":"2009","unstructured":"Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M et al (2009) A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 73:2061\u20132070. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c67808","journal-title":"Neurology"},{"key":"4449_CR102","doi-asserted-by":"publisher","first-page":"8913","DOI":"10.1073\/pnas.1207022109","volume":"109","author":"C Frieden","year":"2012","unstructured":"Frieden C, Garai K (2012) Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer\u2019s disease. Proc Natl Acad Sci USA 109:8913\u20138918. https:\/\/doi.org\/10.1073\/pnas.1207022109","journal-title":"Proc Natl Acad Sci USA"},{"key":"4449_CR103","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","volume":"287","author":"HK Chen","year":"2012","unstructured":"Chen HK, Liu Z, Meyer-Franke A, Brodbeck J, Miranda RD, McGuire JG et al (2012) Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons. J Biol Chem 287:5253\u20135266. https:\/\/doi.org\/10.1074\/jbc.M111.276162","journal-title":"J Biol Chem"},{"key":"4449_CR104","doi-asserted-by":"publisher","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","volume":"286","author":"J Brodbeck","year":"2011","unstructured":"Brodbeck J, McGuire J, Liu Z, Meyer-Franke A, Balestra ME, Jeong DE et al (2011) Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors. J Biol Chem 286:17217\u201317226. https:\/\/doi.org\/10.1074\/jbc.M110.217380","journal-title":"J Biol Chem"},{"key":"4449_CR105","doi-asserted-by":"publisher","first-page":"8997","DOI":"10.1021\/jm3008618","volume":"55","author":"RW Mahley","year":"2012","unstructured":"Mahley RW, Huang Y (2012) Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology. J Med Chem 55:8997\u20139008. https:\/\/doi.org\/10.1021\/jm3008618","journal-title":"J Med Chem"},{"key":"4449_CR106","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1084\/jem.20121274","volume":"209","author":"J Kim","year":"2012","unstructured":"Kim J, Eltorai AE, Jiang H, Liao F, Verghese PB, Kim J et al (2012) Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of A\u03b2 amyloidosis. J Exp Med 209:2149\u20132156. https:\/\/doi.org\/10.1084\/jem.20121274","journal-title":"J Exp Med"},{"key":"4449_CR107","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/jneurosci.0646-14.2014","volume":"34","author":"F Liao","year":"2014","unstructured":"Liao F, Hori Y, Hudry E, Bauer AQ, Jiang H, Mahan TE et al (2014) Anti-ApoE antibody given after plaque onset decreases A\u03b2 accumulation and improves brain function in a mouse model of A\u03b2 amyloidosis. J Neurosci 34:7281\u20137292. https:\/\/doi.org\/10.1523\/jneurosci.0646-14.2014","journal-title":"J Neurosci"},{"key":"4449_CR108","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1567205013666160404120817","volume":"13","author":"I Luz","year":"2016","unstructured":"Luz I, Liraz O, Michaelson DM (2016) An Anti-apoE4 Specific Monoclonal Antibody Counteracts the Pathological Effects of apoE4 In Vivo. Curr Alzheimer Res 13:918\u2013929. https:\/\/doi.org\/10.2174\/1567205013666160404120817","journal-title":"Curr Alzheimer Res"},{"key":"4449_CR109","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/jci96429","volume":"128","author":"F Liao","year":"2018","unstructured":"Liao F, Li A, Xiong M, Bien-Ly N, Jiang H, Zhang Y et al (2018) Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Investig 128:2144\u20132155. https:\/\/doi.org\/10.1172\/jci96429","journal-title":"J Clin Investig"},{"key":"4449_CR110","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/ana.26351","volume":"91","author":"M Gratuze","year":"2022","unstructured":"Gratuze M, Jiang H, Wang C, Xiong M, Bao X, Holtzman DM (2022) APOE Antibody Inhibits A\u03b2-Associated Tau Seeding and Spreading in a Mouse Model. Ann Neurol 91:847\u2013852. https:\/\/doi.org\/10.1002\/ana.26351","journal-title":"Ann Neurol"},{"key":"4449_CR111","doi-asserted-by":"publisher","unstructured":"Xiong M, Jiang H, Serrano JR, Gonzales ER, Wang C, Gratuze M et al (2021) APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Science translational medicine, 13. https:\/\/doi.org\/10.1126\/scitranslmed.abd7522","DOI":"10.1126\/scitranslmed.abd7522"},{"key":"4449_CR112","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/alz.13436","volume":"20","author":"C Marino","year":"2024","unstructured":"Marino C, Perez-Corredor P, O\u2019Hare M, Heuer A, Chmielewska N, Gordon H et al (2024) APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation. Alzheimer\u2019s Dementia 20:819\u2013836. https:\/\/doi.org\/10.1002\/alz.13436","journal-title":"Alzheimer's Dementia"},{"key":"4449_CR113","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","volume":"87","author":"MM Evers","year":"2015","unstructured":"Evers MM, Toonen LJ, van Roon-Mom WM (2015) Antisense oligonucleotides in therapy for neurodegenerative disorders. Adv Drug Deliv Rev 87:90\u2013103. https:\/\/doi.org\/10.1016\/j.addr.2015.03.008","journal-title":"Adv Drug Deliv Rev"},{"key":"4449_CR114","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","volume":"96","author":"TV Huynh","year":"2017","unstructured":"Huynh TV, Liao F, Francis CM, Robinson GO, Serrano JR, Jiang H et al (2017) Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of \u03b2-amyloidosis. Neuron 96:1013-1023.e1014. https:\/\/doi.org\/10.1016\/j.neuron.2017.11.014","journal-title":"Neuron"},{"key":"4449_CR115","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.26043","volume":"89","author":"A Litvinchuk","year":"2021","unstructured":"Litvinchuk A, Huynh TV, Shi Y, Jackson RJ, Finn MB, Manis M et al (2021) Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model. Ann Neurol 89:952\u2013966. https:\/\/doi.org\/10.1002\/ana.26043","journal-title":"Ann Neurol"},{"key":"4449_CR116","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1073\/pnas.0409072102","volume":"102","author":"JC Dodart","year":"2005","unstructured":"Dodart JC, Marr RA, Koistinaho M, Gregersen BM, Malkani S, Verma IM et al (2005) Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA 102:1211\u20131216. https:\/\/doi.org\/10.1073\/pnas.0409072102","journal-title":"Proc Natl Acad Sci USA"},{"key":"4449_CR117","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","volume":"10","author":"J Hu","year":"2015","unstructured":"Hu J, Liu CC, Chen XF, Zhang YW, Xu H, Bu G (2015) Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and A\u03b2 metabolism in apoE4-targeted replacement mice. Mol Neurodegener 10:6. https:\/\/doi.org\/10.1186\/s13024-015-0001-3","journal-title":"Mol Neurodegener"},{"key":"4449_CR118","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1021\/acs.molpharmaceut.0c00461","volume":"18","author":"S Arora","year":"2021","unstructured":"Arora S, Layek B, Singh J (2021) Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer\u2019s Disease. Mol Pharm 18:714\u2013725. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00461","journal-title":"Mol Pharm"},{"key":"4449_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.864828","volume":"16","author":"RC Meza","year":"2022","unstructured":"Meza RC, Ancat\u00e9n-Gonz\u00e1lez C, Chiu CQ, Ch\u00e1vez AE (2022) Transient Receptor Potential Vanilloid 1 Function at Central Synapses in Health and Disease. Front Cell Neurosci 16:864828. https:\/\/doi.org\/10.3389\/fncel.2022.864828","journal-title":"Front Cell Neurosci"},{"key":"4449_CR120","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s12276-023-00935-z","volume":"55","author":"C Wang","year":"2023","unstructured":"Wang C, Lu J, Sha X, Qiu Y, Chen H, Yu Z (2023) TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia. Exp Mol Med 55:347\u2013363. https:\/\/doi.org\/10.1038\/s12276-023-00935-z","journal-title":"Exp Mol Med"},{"key":"4449_CR121","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3233\/jad-160182","volume":"53","author":"S Salomon-Zimri","year":"2016","unstructured":"Salomon-Zimri S, Glat MJ, Barhum Y, Luz I, Boehm-Cagan A, Liraz O et al (2016) Reversal of ApoE4-Driven Brain Pathology by Vascular Endothelial Growth Factor Treatment. J Alzheimers Dis 53:1443\u20131458. https:\/\/doi.org\/10.3233\/jad-160182","journal-title":"J Alzheimers Dis"},{"key":"4449_CR122","doi-asserted-by":"publisher","unstructured":"Xian X, Pohlkamp T, Durakoglugil MS, Wong CH, Beck JK, Lane-Donovan C et al (2018) Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer's disease. eLife, 7. https:\/\/doi.org\/10.7554\/eLife.40048","DOI":"10.7554\/eLife.40048"},{"key":"4449_CR123","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12974-015-0244-5","volume":"12","author":"PK Chang","year":"2015","unstructured":"Chang PK, Khatchadourian A, McKinney RA, Maysinger D (2015) Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology. J Neuroinflammation 12:34. https:\/\/doi.org\/10.1186\/s12974-015-0244-5","journal-title":"J Neuroinflammation"},{"key":"4449_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107649","volume":"31","author":"H Cao","year":"2020","unstructured":"Cao H, Li MY, Li G, Li SJ, Wen B, Lu Y et al (2020) Retinoid X Receptor \u03b1 Regulates DHA-Dependent Spinogenesis and Functional Synapse Formation In Vivo. Cell Rep 31:107649. https:\/\/doi.org\/10.1016\/j.celrep.2020.107649","journal-title":"Cell Rep"},{"key":"4449_CR125","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1471-4159.2009.06335.x","volume":"111","author":"D Cao","year":"2009","unstructured":"Cao D, Kevala K, Kim J, Moon HS, Jun SB, Lovinger D et al (2009) Docosahexaenoic acid promotes hippocampal neuronal development and synaptic function. J Neurochem 111:510\u2013521. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06335.x","journal-title":"J Neurochem"},{"key":"4449_CR126","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/jamaneurol.2016.4899","volume":"74","author":"HN Yassine","year":"2017","unstructured":"Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS et al (2017) Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E \u03b54 Carriers: A Review. JAMA Neurol 74:339\u2013347. https:\/\/doi.org\/10.1001\/jamaneurol.2016.4899","journal-title":"JAMA Neurol"},{"key":"4449_CR127","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3233\/jad-2011-111265","volume":"28","author":"Z Kariv-Inbal","year":"2012","unstructured":"Kariv-Inbal Z, Yacobson S, Berkecz R, Peter M, Janaky T, L\u00fctjohann D et al (2012) The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol. J Alzheimers Dis 28:667\u2013683. https:\/\/doi.org\/10.3233\/jad-2011-111265","journal-title":"J Alzheimers Dis"},{"key":"4449_CR128","doi-asserted-by":"publisher","unstructured":"Mi W, van Wijk N, Cansev M, Sijben JW, Kamphuis PJ (2013) Nutritional approaches in the risk reduction and management of Alzheimer's disease. Nutrition (Burbank, Los Angeles County, Calif.), 29:1080\u20131089. https:\/\/doi.org\/10.1016\/j.nut.2013.01.024","DOI":"10.1016\/j.nut.2013.01.024"},{"key":"4449_CR129","doi-asserted-by":"publisher","first-page":"6846721","DOI":"10.1155\/2016\/6846721","volume":"2016","author":"M Wiesmann","year":"2016","unstructured":"Wiesmann M, Zerbi V, Jansen D, Haast R, Lutjohann D, Broersen LM et al (2016) A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice. Neural Plast 2016:6846721. https:\/\/doi.org\/10.1155\/2016\/6846721","journal-title":"Neural Plast"},{"key":"4449_CR130","doi-asserted-by":"publisher","unstructured":"Uni\u00f3n-Caballero A, Mero\u00f1o T, Andr\u00e9s-Lacueva C, Hidalgo-Liberona N, Rabassa M, Bandinelli S et al (2023) Apolipoprotein E gene variants shape the association between dietary fibre intake and cognitive decline risk in community-dwelling older adults. Age and ageing, 52. https:\/\/doi.org\/10.1093\/ageing\/afac329","DOI":"10.1093\/ageing\/afac329"},{"key":"4449_CR131","doi-asserted-by":"publisher","unstructured":"Norwitz NG, Saif N, Ariza IE, Isaacson RS (2021) Precision Nutrition for Alzheimer's Prevention in ApoE4 Carriers. Nutrients, 13. https:\/\/doi.org\/10.3390\/nu13041362","DOI":"10.3390\/nu13041362"},{"key":"4449_CR132","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/mp.2012.162","volume":"18","author":"BM Brown","year":"2013","unstructured":"Brown BM, Peiffer JJ, Martins RN (2013) Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer\u2019s disease? Mol Psychiatry 18:864\u2013874. https:\/\/doi.org\/10.1038\/mp.2012.162","journal-title":"Mol Psychiatry"},{"key":"4449_CR133","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1097\/00005768-200105000-00015","volume":"33","author":"AJ Schuit","year":"2001","unstructured":"Schuit AJ, Feskens EJ, Launer LJ, Kromhout D (2001) Physical activity and cognitive decline, the role of the apolipoprotein e4 allele. Med Sci Sports Exerc 33:772\u2013777. https:\/\/doi.org\/10.1097\/00005768-200105000-00015","journal-title":"Med Sci Sports Exerc"},{"key":"4449_CR134","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1177\/0271678x21990342","volume":"41","author":"CS Kaufman","year":"2021","unstructured":"Kaufman CS, Honea RA, Pleen J, Lepping RJ, Watts A, Morris JK et al (2021) Aerobic exercise improves hippocampal blood flow for hypertensive Apolipoprotein E4 carriers. Journal of cerebral blood flow and metabolism\u202f: official journal of the International Society of Cerebral Blood Flow and Metabolism 41:2026\u20132037. https:\/\/doi.org\/10.1177\/0271678x21990342","journal-title":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"4449_CR135","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13195-023-01170-4","volume":"15","author":"LJ de Frutos","year":"2023","unstructured":"de Frutos LJ, Sewell KR, Garc\u00eda-Colomo A, Markovic S, Erickson KI, Brown BM (2023) How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer\u2019s disease risk? A novel integrative model. Alzheimer\u2019s research & therapy 15:22. https:\/\/doi.org\/10.1186\/s13195-023-01170-4","journal-title":"Alzheimer's research & therapy"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04449-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04449-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04449-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T06:02:54Z","timestamp":1738562574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04449-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":135,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["4449"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04449-1","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,31]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have given final approval of the version and agreed with the publication of this study here.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflict of interest. Figures were created by Figdraw ().","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}